» Articles » PMID: 37033132

Premature Progesterone Elevation in Fertilisation Cycles - Current Perspectives

Overview
Date 2023 Apr 10
PMID 37033132
Authors
Affiliations
Soon will be listed here.
Abstract

The impact of premature elevation of progesterone (PPE) on the day of the trigger on pregnancy outcome in fertilisation (IVF) cycles has been a matter of contention and debate for decades. Research over the last 30 years has indicated that PPE >1.5 ng/ml is associated with declining live birth rates following fresh embryo transfer. Freeze-only approach has become a universal solution to overcome the issue of PPE. However, the topic is still mired with controversy. Few studies have not shown a negative impact on pregnancy rates. The impact of PPE on embryological parameters such as oocyte and embryo quality and ploidy is still very controversial. An important contentious issue is the choice of the threshold P value above which it is considered abnormal and a freeze-all strategy would be cost-effective. Currently, though a cutoff of >1.5 ng/ml is widely used, practices are not uniform and varying thresholds from 0.4 to 3 ng/ml are utilised. This review addresses the current understanding of PPE in IVF and the above controversies. The incidence, aetiology and source of progesterone rise, impact on endometrial receptivity, oocyte and embryo quality, impact on live birth and cumulative live birth and impact on frozen embryo transfer and donor oocyte cycles are discussed. Current controversies regarding the optimal threshold, assay performance and future directions are addressed.

Citing Articles

Association Between Progesterone Level on Trigger Day to Basal Progesterone Ratio and in vitro Fertilization-Embryo Transfer Outcomes in Antagonist Protocols.

Xu M, Wang Y, Liu Y Int J Womens Health. 2025; 17:663-671.

PMID: 40078508 PMC: 11900791. DOI: 10.2147/IJWH.S506574.


The study on the clinical efficacy of endometrial receptivity analysis and influence factors of displaced window of implantation.

Xu S, Diao H, Xiong Y, Zhang C, Zhang Y, Zhang Y Sci Rep. 2025; 15(1):7326.

PMID: 40025209 PMC: 11873133. DOI: 10.1038/s41598-025-91745-y.

References
1.
Huang B, Ren X, Wu L, Zhu L, Xu B, Li Y . Elevated Progesterone Levels on the Day of Oocyte Maturation May Affect Top Quality Embryo IVF Cycles. PLoS One. 2016; 11(1):e0145895. PMC: 4706317. DOI: 10.1371/journal.pone.0145895. View

2.
Demir B, Kahyaoglu I, Guvenir A, Yerebasmaz N, Altinbas S, Dilbaz B . Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cycles. Gynecol Endocrinol. 2015; 32(5):361-5. PMC: 4841018. DOI: 10.3109/09513590.2015.1121226. View

3.
Griesinger G, Mannaerts B, Andersen C, Witjes H, Kolibianakis E, Gordon K . Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertil Steril. 2013; 100(6):1622-8.e1-3. DOI: 10.1016/j.fertnstert.2013.08.045. View

4.
Venetis C, Tarlatzis B . Trying to define the optimal progesterone elevation cut-off in fresh in vitro fertilization cycles: time to evolve our way of thinking. Fertil Steril. 2018; 110(4):634-635. DOI: 10.1016/j.fertnstert.2018.06.006. View

5.
Haouzi D, Bissonnette L, Gala A, Assou S, Entezami F, Perrochia H . Endometrial receptivity profile in patients with premature progesterone elevation on the day of HCG administration. Biomed Res Int. 2014; 2014:951937. PMC: 4022194. DOI: 10.1155/2014/951937. View